What is the average price target for SALESFORCE INC (CRM) stock?
58 analysts have analysed CRM and the average price target is 278.01 USD. This implies a price increase of 55.05% is expected in the next year compared to the current price of 179.31.
NYSE:CRM • US79466L3024
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SALESFORCE INC (CRM).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-10 | Northland Capital Markets | Maintains | Market Perform -> Market Perform |
| 2026-03-02 | Citigroup | Maintains | Neutral -> Neutral |
| 2026-02-27 | DA Davidson | Maintains | Neutral -> Neutral |
| 2026-02-26 | TD Cowen | Maintains | Buy -> Buy |
| 2026-02-26 | Macquarie | Maintains | Neutral -> Neutral |
| 2026-02-26 | Bernstein | Maintains | Underperform -> Underperform |
| 2026-02-26 | Mizuho | Maintains | Outperform -> Outperform |
| 2026-02-26 | BMO Capital | Maintains | Outperform -> Outperform |
| 2026-02-26 | BTIG | Maintains | Buy -> Buy |
| 2026-02-26 | Needham | Reiterate | Buy -> Buy |
| 2026-02-26 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2026-02-26 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2026-02-26 | Stifel | Maintains | Buy -> Buy |
| 2026-02-26 | Barclays | Maintains | Overweight -> Overweight |
| 2026-02-26 | Wedbush | Maintains | Outperform -> Outperform |
| 2026-02-26 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2026-02-26 | Roth Capital | Maintains | Buy -> Buy |
| 2026-02-26 | JP Morgan | Maintains | Overweight -> Overweight |
| 2026-02-26 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2026-02-24 | Keybanc | Maintains | Overweight -> Overweight |
| 2026-02-24 | Wedbush | Reiterate | Outperform -> Outperform |
| 2026-02-23 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2026-02-23 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2026-02-23 | Jefferies | Maintains | Buy -> Buy |
| 2026-02-18 | BTIG | Maintains | Buy -> Buy |
| 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 34.857B 11.18% | 37.895B 8.72% | 41.525B 9.58% | 46.592B 12.20% | 51.012B 9.49% | 55.854B 9.49% | 60.864B 8.97% | 66.83B 9.80% | 76.144B 13.94% | 84.787B 11.35% | 94.64B 11.62% | |
| EBITDA YoY % growth | 9.958B 76.44% | 11.143B 11.90% | 12.548B 12.61% | 19.647B 56.57% | 21.452B 9.19% | 23.252B 8.39% | 25.137B 8.11% | 17.821B -29.10% | 19.691B 10.49% | 21.718B 10.29% | N/A | |
| EBIT YoY % growth | 5.999B 222.87% | 7.666B 27.79% | 8.917B 16.32% | 15.989B 79.31% | 17.938B 12.19% | 19.277B 7.46% | 24.767B 28.48% | N/A | N/A | N/A | N/A | |
| Operating Margin | 17.21% | 20.23% | 21.47% | 34.32% | 35.16% | 34.51% | 40.69% | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | 8.21 56.38% | 10.19 24.12% | 12.55 23.16% | 13.29 5.86% | 14.98 12.76% | 17.86 19.23% | 20.62 15.43% | 22.31 8.19% | 28.45 27.55% | 33.42 17.47% | 39.00 16.68% |
All data in USD
| Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | Q1 / 29 | Q2 / 29 | Q3 / 29 | Q4 / 29 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 3.15 22.01% | 3.27 12.40% | 3.34 2.87% | 3.57 -6.29% | 3.47 10.08% | 3.68 12.38% | 3.75 12.08% | 4.05 13.32% | 3.95 13.86% | 4.18 13.67% | 4.32 15.38% | 4.55 12.44% |
| Revenue Q2Q % growth | 11.162B 13.56% | 11.465B 12.01% | 11.56B 12.68% | 12.355B 10.30% | 12.173B 9.06% | 12.524B 9.24% | 12.652B 9.45% | 13.537B 9.57% | 13.511B 10.99% | 13.951B 11.39% | 14.076B 11.26% | 15.159B 11.98% |
| EBITDA Q2Q % growth | 4.683B 66.00% | 4.826B 20.77% | 4.942B -0.34% | 5.232B -9.57% | 5.048B 7.79% | 5.332B 10.48% | 5.483B 10.95% | 5.733B 9.58% | 5.604B 11.01% | 5.913B 10.90% | 6.086B 11.00% | 6.32B 10.24% |
| EBIT Q2Q % growth | 3.732B 88.68% | 3.93B 68.24% | 4.022B 64.30% | 4.299B 99.49% | 4.148B 11.15% | 4.389B 11.68% | 4.484B 11.49% | 4.838B 12.54% | 4.71B 13.55% | 5.014B 14.24% | 5.182B 15.57% | 5.398B 11.58% |
All data in USD
58 analysts have analysed CRM and the average price target is 278.01 USD. This implies a price increase of 55.05% is expected in the next year compared to the current price of 179.31.
SALESFORCE INC (CRM) will report earnings on 2026-05-26, after the market close.
The consensus EPS estimate for the next earnings of SALESFORCE INC (CRM) is 3.15 USD and the consensus revenue estimate is 11.16B USD.
The number of analysts covering SALESFORCE INC (CRM) is 58.